nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromocriptine—CYP3A4—prostate cancer	0.102	1	CbGaD
Bromocriptine—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0386	0.0884	CbGbCtD
Bromocriptine—CYP1A2—Flutamide—prostate cancer	0.032	0.0735	CbGbCtD
Bromocriptine—ABCB1—Estramustine—prostate cancer	0.0314	0.0721	CbGbCtD
Bromocriptine—CYP1A2—Estrone—prostate cancer	0.0232	0.0531	CbGbCtD
Bromocriptine—ADRA1B—vas deferens—prostate cancer	0.0223	0.322	CbGeAlD
Bromocriptine—ABCB1—Cabazitaxel—prostate cancer	0.0207	0.0475	CbGbCtD
Bromocriptine—CYP3A4—Bicalutamide—prostate cancer	0.0203	0.0465	CbGbCtD
Bromocriptine—ABCB1—Estrone—prostate cancer	0.0203	0.0465	CbGbCtD
Bromocriptine—CYP3A4—Estramustine—prostate cancer	0.0188	0.0432	CbGbCtD
Bromocriptine—ABCB1—Ethinyl Estradiol—prostate cancer	0.0181	0.0414	CbGbCtD
Bromocriptine—CYP3A4—Flutamide—prostate cancer	0.0168	0.0385	CbGbCtD
Bromocriptine—CYP3A4—Abiraterone—prostate cancer	0.0168	0.0385	CbGbCtD
Bromocriptine—CYP1A2—Conjugated Estrogens—prostate cancer	0.0152	0.0348	CbGbCtD
Bromocriptine—CYP1A2—Estradiol—prostate cancer	0.0133	0.0305	CbGbCtD
Bromocriptine—ABCB1—Conjugated Estrogens—prostate cancer	0.0133	0.0304	CbGbCtD
Bromocriptine—HTR7—vas deferens—prostate cancer	0.013	0.187	CbGeAlD
Bromocriptine—CYP3A4—Cabazitaxel—prostate cancer	0.0124	0.0285	CbGbCtD
Bromocriptine—CYP3A4—Estrone—prostate cancer	0.0121	0.0278	CbGbCtD
Bromocriptine—ABCB1—Mitoxantrone—prostate cancer	0.012	0.0276	CbGbCtD
Bromocriptine—ABCB1—Estradiol—prostate cancer	0.0116	0.0267	CbGbCtD
Bromocriptine—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0108	0.0248	CbGbCtD
Bromocriptine—ABCB1—Prednisone—prostate cancer	0.01	0.0229	CbGbCtD
Bromocriptine—CYP1A2—Etoposide—prostate cancer	0.00869	0.0199	CbGbCtD
Bromocriptine—CYP3A4—Conjugated Estrogens—prostate cancer	0.00794	0.0182	CbGbCtD
Bromocriptine—ABCB1—Etoposide—prostate cancer	0.0076	0.0174	CbGbCtD
Bromocriptine—CYP3A4—Mitoxantrone—prostate cancer	0.00722	0.0166	CbGbCtD
Bromocriptine—CYP3A4—Estradiol—prostate cancer	0.00697	0.016	CbGbCtD
Bromocriptine—ABCB1—Docetaxel—prostate cancer	0.00695	0.0159	CbGbCtD
Bromocriptine—CYP3A4—Prednisone—prostate cancer	0.00599	0.0137	CbGbCtD
Bromocriptine—ABCB1—Doxorubicin—prostate cancer	0.00518	0.0119	CbGbCtD
Bromocriptine—CYP3A4—Etoposide—prostate cancer	0.00455	0.0104	CbGbCtD
Bromocriptine—CYP3A4—Docetaxel—prostate cancer	0.00416	0.00955	CbGbCtD
Bromocriptine—CYP3A4—Doxorubicin—prostate cancer	0.0031	0.00712	CbGbCtD
Bromocriptine—CYP1A2—urine—prostate cancer	0.00258	0.0372	CbGeAlD
Bromocriptine—HTR2A—urine—prostate cancer	0.00202	0.0291	CbGeAlD
Bromocriptine—ADRA1D—prostate gland—prostate cancer	0.00195	0.0281	CbGeAlD
Bromocriptine—CYP3A4—urine—prostate cancer	0.00187	0.0269	CbGeAlD
Bromocriptine—DRD4—testis—prostate cancer	0.00163	0.0234	CbGeAlD
Bromocriptine—ADRA1D—epithelium—prostate cancer	0.00143	0.0206	CbGeAlD
Bromocriptine—ADRB1—prostate gland—prostate cancer	0.00142	0.0204	CbGeAlD
Bromocriptine—ADRA1B—renal system—prostate cancer	0.00136	0.0196	CbGeAlD
Bromocriptine—ADRA1D—urethra—prostate cancer	0.0013	0.0188	CbGeAlD
Bromocriptine—ADRA1A—prostate gland—prostate cancer	0.00112	0.0161	CbGeAlD
Bromocriptine—ADRA2C—prostate gland—prostate cancer	0.00107	0.0154	CbGeAlD
Bromocriptine—ADRA2C—seminal vesicle—prostate cancer	0.000902	0.013	CbGeAlD
Bromocriptine—HTR7—epithelium—prostate cancer	0.000853	0.0123	CbGeAlD
Bromocriptine—ADRA2A—prostate gland—prostate cancer	0.000851	0.0123	CbGeAlD
Bromocriptine—HTR1A—renal system—prostate cancer	0.000827	0.0119	CbGeAlD
Bromocriptine—ADRA1A—epithelium—prostate cancer	0.000822	0.0119	CbGeAlD
Bromocriptine—HTR7—renal system—prostate cancer	0.000791	0.0114	CbGeAlD
Bromocriptine—ADRA1A—renal system—prostate cancer	0.000763	0.011	CbGeAlD
Bromocriptine—ADRA2C—renal system—prostate cancer	0.000727	0.0105	CbGeAlD
Bromocriptine—ADRA2A—seminal vesicle—prostate cancer	0.00072	0.0104	CbGeAlD
Bromocriptine—ADRA2C—urethra—prostate cancer	0.000714	0.0103	CbGeAlD
Bromocriptine—CYP1A2—renal system—prostate cancer	0.000631	0.0091	CbGeAlD
Bromocriptine—Ergoloid mesylate—CYP3A4—prostate cancer	0.000571	0.29	CrCbGaD
Bromocriptine—ADRA2A—urethra—prostate cancer	0.00057	0.00822	CbGeAlD
Bromocriptine—HTR2A—epithelium—prostate cancer	0.000532	0.00767	CbGeAlD
Bromocriptine—HTR7—testis—prostate cancer	0.000511	0.00737	CbGeAlD
Bromocriptine—HTR2A—renal system—prostate cancer	0.000493	0.00711	CbGeAlD
Bromocriptine—DRD2—testis—prostate cancer	0.000483	0.00697	CbGeAlD
Bromocriptine—ABCB1—prostate gland—prostate cancer	0.000474	0.00684	CbGeAlD
Bromocriptine—ADRA2C—testis—prostate cancer	0.00047	0.00677	CbGeAlD
Bromocriptine—CYP3A4—renal system—prostate cancer	0.000457	0.00658	CbGeAlD
Bromocriptine—HTR2B—lymph node—prostate cancer	0.000433	0.00624	CbGeAlD
Bromocriptine—Dihydroergotamine—CYP3A4—prostate cancer	0.000433	0.22	CrCbGaD
Bromocriptine—ABCB1—seminal vesicle—prostate cancer	0.000401	0.00578	CbGeAlD
Bromocriptine—Ergonovine—CYP3A4—prostate cancer	0.000396	0.201	CrCbGaD
Bromocriptine—ADRA2A—testis—prostate cancer	0.000375	0.00541	CbGeAlD
Bromocriptine—ABCB1—epithelium—prostate cancer	0.000348	0.00502	CbGeAlD
Bromocriptine—Methylergometrine—CYP3A4—prostate cancer	0.000346	0.176	CrCbGaD
Bromocriptine—ADRA2C—lymph node—prostate cancer	0.000341	0.00491	CbGeAlD
Bromocriptine—ABCB1—renal system—prostate cancer	0.000323	0.00466	CbGeAlD
Bromocriptine—HTR2A—testis—prostate cancer	0.000319	0.0046	CbGeAlD
Bromocriptine—ABCB1—urethra—prostate cancer	0.000317	0.00458	CbGeAlD
Bromocriptine—ADRA2A—lymph node—prostate cancer	0.000272	0.00392	CbGeAlD
Bromocriptine—ABCB1—bone marrow—prostate cancer	0.000244	0.00352	CbGeAlD
Bromocriptine—Ergotamine—CYP3A4—prostate cancer	0.000223	0.113	CrCbGaD
Bromocriptine—ABCB1—testis—prostate cancer	0.000209	0.00301	CbGeAlD
Bromocriptine—ABCB1—lymph node—prostate cancer	0.000151	0.00218	CbGeAlD
Bromocriptine—Fatigue—Etoposide—prostate cancer	9.09e-05	0.000383	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	9.08e-05	0.000382	CcSEcCtD
Bromocriptine—Constipation—Etoposide—prostate cancer	9.02e-05	0.00038	CcSEcCtD
Bromocriptine—Dizziness—Estradiol—prostate cancer	9e-05	0.000379	CcSEcCtD
Bromocriptine—Hypertension—Capecitabine—prostate cancer	8.98e-05	0.000378	CcSEcCtD
Bromocriptine—Dry mouth—Docetaxel—prostate cancer	8.94e-05	0.000377	CcSEcCtD
Bromocriptine—Pollakiuria—Doxorubicin—prostate cancer	8.89e-05	0.000374	CcSEcCtD
Bromocriptine—Confusional state—Docetaxel—prostate cancer	8.84e-05	0.000372	CcSEcCtD
Bromocriptine—Anxiety—Capecitabine—prostate cancer	8.82e-05	0.000371	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	8.79e-05	0.00037	CcSEcCtD
Bromocriptine—Oedema—Docetaxel—prostate cancer	8.77e-05	0.000369	CcSEcCtD
Bromocriptine—Vision blurred—Prednisone—prostate cancer	8.73e-05	0.000368	CcSEcCtD
Bromocriptine—Infection—Docetaxel—prostate cancer	8.71e-05	0.000367	CcSEcCtD
Bromocriptine—Sinusitis—Epirubicin—prostate cancer	8.7e-05	0.000366	CcSEcCtD
Bromocriptine—Feeling abnormal—Etoposide—prostate cancer	8.69e-05	0.000366	CcSEcCtD
Bromocriptine—Diarrhoea—Mitoxantrone—prostate cancer	8.68e-05	0.000365	CcSEcCtD
Bromocriptine—Dry mouth—Capecitabine—prostate cancer	8.66e-05	0.000365	CcSEcCtD
Bromocriptine—Vomiting—Estradiol—prostate cancer	8.65e-05	0.000364	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Etoposide—prostate cancer	8.63e-05	0.000363	CcSEcCtD
Bromocriptine—Shock—Docetaxel—prostate cancer	8.62e-05	0.000363	CcSEcCtD
Bromocriptine—Nervous system disorder—Docetaxel—prostate cancer	8.6e-05	0.000362	CcSEcCtD
Bromocriptine—Rash—Estradiol—prostate cancer	8.58e-05	0.000361	CcSEcCtD
Bromocriptine—Drowsiness—Doxorubicin—prostate cancer	8.58e-05	0.000361	CcSEcCtD
Bromocriptine—Dermatitis—Estradiol—prostate cancer	8.57e-05	0.000361	CcSEcCtD
Bromocriptine—Confusional state—Capecitabine—prostate cancer	8.56e-05	0.00036	CcSEcCtD
Bromocriptine—Tachycardia—Docetaxel—prostate cancer	8.56e-05	0.00036	CcSEcCtD
Bromocriptine—Headache—Estradiol—prostate cancer	8.53e-05	0.000359	CcSEcCtD
Bromocriptine—Skin disorder—Docetaxel—prostate cancer	8.51e-05	0.000359	CcSEcCtD
Bromocriptine—Agitation—Prednisone—prostate cancer	8.51e-05	0.000358	CcSEcCtD
Bromocriptine—Oedema—Capecitabine—prostate cancer	8.49e-05	0.000357	CcSEcCtD
Bromocriptine—Bradycardia—Epirubicin—prostate cancer	8.47e-05	0.000357	CcSEcCtD
Bromocriptine—Infection—Capecitabine—prostate cancer	8.43e-05	0.000355	CcSEcCtD
Bromocriptine—Urticaria—Etoposide—prostate cancer	8.38e-05	0.000353	CcSEcCtD
Bromocriptine—Anorexia—Docetaxel—prostate cancer	8.36e-05	0.000352	CcSEcCtD
Bromocriptine—Shock—Capecitabine—prostate cancer	8.35e-05	0.000352	CcSEcCtD
Bromocriptine—Rhinitis—Epirubicin—prostate cancer	8.34e-05	0.000351	CcSEcCtD
Bromocriptine—Body temperature increased—Etoposide—prostate cancer	8.34e-05	0.000351	CcSEcCtD
Bromocriptine—Abdominal pain—Etoposide—prostate cancer	8.34e-05	0.000351	CcSEcCtD
Bromocriptine—Nervous system disorder—Capecitabine—prostate cancer	8.32e-05	0.00035	CcSEcCtD
Bromocriptine—Vertigo—Prednisone—prostate cancer	8.32e-05	0.00035	CcSEcCtD
Bromocriptine—Syncope—Prednisone—prostate cancer	8.31e-05	0.00035	CcSEcCtD
Bromocriptine—Tachycardia—Capecitabine—prostate cancer	8.28e-05	0.000349	CcSEcCtD
Bromocriptine—Hypoaesthesia—Epirubicin—prostate cancer	8.28e-05	0.000349	CcSEcCtD
Bromocriptine—Skin disorder—Capecitabine—prostate cancer	8.24e-05	0.000347	CcSEcCtD
Bromocriptine—Oedema peripheral—Epirubicin—prostate cancer	8.2e-05	0.000345	CcSEcCtD
Bromocriptine—Hypotension—Docetaxel—prostate cancer	8.19e-05	0.000345	CcSEcCtD
Bromocriptine—Connective tissue disorder—Epirubicin—prostate cancer	8.18e-05	0.000344	CcSEcCtD
Bromocriptine—Loss of consciousness—Prednisone—prostate cancer	8.14e-05	0.000343	CcSEcCtD
Bromocriptine—Anorexia—Capecitabine—prostate cancer	8.09e-05	0.000341	CcSEcCtD
Bromocriptine—Nausea—Estradiol—prostate cancer	8.08e-05	0.00034	CcSEcCtD
Bromocriptine—Vomiting—Mitoxantrone—prostate cancer	8.06e-05	0.000339	CcSEcCtD
Bromocriptine—Sinusitis—Doxorubicin—prostate cancer	8.05e-05	0.000339	CcSEcCtD
Bromocriptine—Convulsion—Prednisone—prostate cancer	8.03e-05	0.000338	CcSEcCtD
Bromocriptine—Visual impairment—Epirubicin—prostate cancer	8.02e-05	0.000338	CcSEcCtD
Bromocriptine—Hypertension—Prednisone—prostate cancer	8e-05	0.000337	CcSEcCtD
Bromocriptine—Rash—Mitoxantrone—prostate cancer	8e-05	0.000337	CcSEcCtD
Bromocriptine—Dermatitis—Mitoxantrone—prostate cancer	7.99e-05	0.000336	CcSEcCtD
Bromocriptine—Headache—Mitoxantrone—prostate cancer	7.94e-05	0.000334	CcSEcCtD
Bromocriptine—Hypotension—Capecitabine—prostate cancer	7.93e-05	0.000334	CcSEcCtD
Bromocriptine—Insomnia—Docetaxel—prostate cancer	7.93e-05	0.000334	CcSEcCtD
Bromocriptine—Paraesthesia—Docetaxel—prostate cancer	7.87e-05	0.000331	CcSEcCtD
Bromocriptine—Anxiety—Prednisone—prostate cancer	7.86e-05	0.000331	CcSEcCtD
Bromocriptine—Bradycardia—Doxorubicin—prostate cancer	7.84e-05	0.00033	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	7.83e-05	0.00033	CcSEcCtD
Bromocriptine—Dyspnoea—Docetaxel—prostate cancer	7.81e-05	0.000329	CcSEcCtD
Bromocriptine—Somnolence—Docetaxel—prostate cancer	7.79e-05	0.000328	CcSEcCtD
Bromocriptine—Eye disorder—Epirubicin—prostate cancer	7.78e-05	0.000327	CcSEcCtD
Bromocriptine—Tinnitus—Epirubicin—prostate cancer	7.76e-05	0.000327	CcSEcCtD
Bromocriptine—Cardiac disorder—Epirubicin—prostate cancer	7.72e-05	0.000325	CcSEcCtD
Bromocriptine—Rhinitis—Doxorubicin—prostate cancer	7.72e-05	0.000325	CcSEcCtD
Bromocriptine—Dyspepsia—Docetaxel—prostate cancer	7.72e-05	0.000325	CcSEcCtD
Bromocriptine—Insomnia—Capecitabine—prostate cancer	7.68e-05	0.000323	CcSEcCtD
Bromocriptine—Hypoaesthesia—Doxorubicin—prostate cancer	7.66e-05	0.000323	CcSEcCtD
Bromocriptine—Paraesthesia—Capecitabine—prostate cancer	7.62e-05	0.000321	CcSEcCtD
Bromocriptine—Decreased appetite—Docetaxel—prostate cancer	7.62e-05	0.000321	CcSEcCtD
Bromocriptine—Oedema peripheral—Doxorubicin—prostate cancer	7.59e-05	0.000319	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Docetaxel—prostate cancer	7.57e-05	0.000319	CcSEcCtD
Bromocriptine—Asthenia—Etoposide—prostate cancer	7.57e-05	0.000319	CcSEcCtD
Bromocriptine—Connective tissue disorder—Doxorubicin—prostate cancer	7.57e-05	0.000319	CcSEcCtD
Bromocriptine—Dyspnoea—Capecitabine—prostate cancer	7.57e-05	0.000319	CcSEcCtD
Bromocriptine—Oedema—Prednisone—prostate cancer	7.56e-05	0.000318	CcSEcCtD
Bromocriptine—Fatigue—Docetaxel—prostate cancer	7.56e-05	0.000318	CcSEcCtD
Bromocriptine—Angiopathy—Epirubicin—prostate cancer	7.55e-05	0.000318	CcSEcCtD
Bromocriptine—Nausea—Mitoxantrone—prostate cancer	7.53e-05	0.000317	CcSEcCtD
Bromocriptine—Infection—Prednisone—prostate cancer	7.51e-05	0.000316	CcSEcCtD
Bromocriptine—Mediastinal disorder—Epirubicin—prostate cancer	7.5e-05	0.000316	CcSEcCtD
Bromocriptine—Constipation—Docetaxel—prostate cancer	7.5e-05	0.000316	CcSEcCtD
Bromocriptine—Dyspepsia—Capecitabine—prostate cancer	7.47e-05	0.000315	CcSEcCtD
Bromocriptine—Shock—Prednisone—prostate cancer	7.44e-05	0.000313	CcSEcCtD
Bromocriptine—Arrhythmia—Epirubicin—prostate cancer	7.43e-05	0.000313	CcSEcCtD
Bromocriptine—Visual impairment—Doxorubicin—prostate cancer	7.42e-05	0.000312	CcSEcCtD
Bromocriptine—Nervous system disorder—Prednisone—prostate cancer	7.41e-05	0.000312	CcSEcCtD
Bromocriptine—Tachycardia—Prednisone—prostate cancer	7.38e-05	0.000311	CcSEcCtD
Bromocriptine—Decreased appetite—Capecitabine—prostate cancer	7.38e-05	0.000311	CcSEcCtD
Bromocriptine—Alopecia—Epirubicin—prostate cancer	7.35e-05	0.00031	CcSEcCtD
Bromocriptine—Skin disorder—Prednisone—prostate cancer	7.34e-05	0.000309	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Capecitabine—prostate cancer	7.33e-05	0.000309	CcSEcCtD
Bromocriptine—Fatigue—Capecitabine—prostate cancer	7.32e-05	0.000308	CcSEcCtD
Bromocriptine—Mental disorder—Epirubicin—prostate cancer	7.29e-05	0.000307	CcSEcCtD
Bromocriptine—Constipation—Capecitabine—prostate cancer	7.26e-05	0.000306	CcSEcCtD
Bromocriptine—Feeling abnormal—Docetaxel—prostate cancer	7.22e-05	0.000304	CcSEcCtD
Bromocriptine—Diarrhoea—Etoposide—prostate cancer	7.22e-05	0.000304	CcSEcCtD
Bromocriptine—Anorexia—Prednisone—prostate cancer	7.21e-05	0.000303	CcSEcCtD
Bromocriptine—Eye disorder—Doxorubicin—prostate cancer	7.2e-05	0.000303	CcSEcCtD
Bromocriptine—Tinnitus—Doxorubicin—prostate cancer	7.18e-05	0.000302	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Docetaxel—prostate cancer	7.17e-05	0.000302	CcSEcCtD
Bromocriptine—Cardiac disorder—Doxorubicin—prostate cancer	7.15e-05	0.000301	CcSEcCtD
Bromocriptine—Tension—Epirubicin—prostate cancer	7.11e-05	0.000299	CcSEcCtD
Bromocriptine—Dysgeusia—Epirubicin—prostate cancer	7.09e-05	0.000299	CcSEcCtD
Bromocriptine—Nervousness—Epirubicin—prostate cancer	7.04e-05	0.000296	CcSEcCtD
Bromocriptine—Feeling abnormal—Capecitabine—prostate cancer	6.99e-05	0.000294	CcSEcCtD
Bromocriptine—Angiopathy—Doxorubicin—prostate cancer	6.99e-05	0.000294	CcSEcCtD
Bromocriptine—Dizziness—Etoposide—prostate cancer	6.97e-05	0.000294	CcSEcCtD
Bromocriptine—Muscle spasms—Epirubicin—prostate cancer	6.97e-05	0.000293	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Capecitabine—prostate cancer	6.94e-05	0.000292	CcSEcCtD
Bromocriptine—Mediastinal disorder—Doxorubicin—prostate cancer	6.94e-05	0.000292	CcSEcCtD
Bromocriptine—Abdominal pain—Docetaxel—prostate cancer	6.93e-05	0.000292	CcSEcCtD
Bromocriptine—Body temperature increased—Docetaxel—prostate cancer	6.93e-05	0.000292	CcSEcCtD
Bromocriptine—Arrhythmia—Doxorubicin—prostate cancer	6.88e-05	0.00029	CcSEcCtD
Bromocriptine—Insomnia—Prednisone—prostate cancer	6.84e-05	0.000288	CcSEcCtD
Bromocriptine—Vision blurred—Epirubicin—prostate cancer	6.83e-05	0.000287	CcSEcCtD
Bromocriptine—Alopecia—Doxorubicin—prostate cancer	6.8e-05	0.000287	CcSEcCtD
Bromocriptine—Paraesthesia—Prednisone—prostate cancer	6.79e-05	0.000286	CcSEcCtD
Bromocriptine—Mental disorder—Doxorubicin—prostate cancer	6.75e-05	0.000284	CcSEcCtD
Bromocriptine—Urticaria—Capecitabine—prostate cancer	6.74e-05	0.000284	CcSEcCtD
Bromocriptine—Abdominal pain—Capecitabine—prostate cancer	6.71e-05	0.000282	CcSEcCtD
Bromocriptine—Body temperature increased—Capecitabine—prostate cancer	6.71e-05	0.000282	CcSEcCtD
Bromocriptine—Vomiting—Etoposide—prostate cancer	6.71e-05	0.000282	CcSEcCtD
Bromocriptine—Agitation—Epirubicin—prostate cancer	6.66e-05	0.00028	CcSEcCtD
Bromocriptine—Dyspepsia—Prednisone—prostate cancer	6.65e-05	0.00028	CcSEcCtD
Bromocriptine—Rash—Etoposide—prostate cancer	6.65e-05	0.00028	CcSEcCtD
Bromocriptine—Dermatitis—Etoposide—prostate cancer	6.64e-05	0.00028	CcSEcCtD
Bromocriptine—Headache—Etoposide—prostate cancer	6.61e-05	0.000278	CcSEcCtD
Bromocriptine—Tension—Doxorubicin—prostate cancer	6.58e-05	0.000277	CcSEcCtD
Bromocriptine—Decreased appetite—Prednisone—prostate cancer	6.57e-05	0.000277	CcSEcCtD
Bromocriptine—Dysgeusia—Doxorubicin—prostate cancer	6.56e-05	0.000276	CcSEcCtD
Bromocriptine—Fatigue—Prednisone—prostate cancer	6.52e-05	0.000274	CcSEcCtD
Bromocriptine—Nervousness—Doxorubicin—prostate cancer	6.51e-05	0.000274	CcSEcCtD
Bromocriptine—Vertigo—Epirubicin—prostate cancer	6.51e-05	0.000274	CcSEcCtD
Bromocriptine—Syncope—Epirubicin—prostate cancer	6.5e-05	0.000274	CcSEcCtD
Bromocriptine—Constipation—Prednisone—prostate cancer	6.46e-05	0.000272	CcSEcCtD
Bromocriptine—Muscle spasms—Doxorubicin—prostate cancer	6.44e-05	0.000271	CcSEcCtD
Bromocriptine—Loss of consciousness—Epirubicin—prostate cancer	6.37e-05	0.000268	CcSEcCtD
Bromocriptine—Vision blurred—Doxorubicin—prostate cancer	6.32e-05	0.000266	CcSEcCtD
Bromocriptine—Asthenia—Docetaxel—prostate cancer	6.29e-05	0.000265	CcSEcCtD
Bromocriptine—Convulsion—Epirubicin—prostate cancer	6.28e-05	0.000264	CcSEcCtD
Bromocriptine—Nausea—Etoposide—prostate cancer	6.27e-05	0.000264	CcSEcCtD
Bromocriptine—Hypertension—Epirubicin—prostate cancer	6.25e-05	0.000263	CcSEcCtD
Bromocriptine—Feeling abnormal—Prednisone—prostate cancer	6.23e-05	0.000262	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Prednisone—prostate cancer	6.18e-05	0.00026	CcSEcCtD
Bromocriptine—Agitation—Doxorubicin—prostate cancer	6.16e-05	0.000259	CcSEcCtD
Bromocriptine—Anxiety—Epirubicin—prostate cancer	6.15e-05	0.000259	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	6.13e-05	0.000258	CcSEcCtD
Bromocriptine—Asthenia—Capecitabine—prostate cancer	6.09e-05	0.000256	CcSEcCtD
Bromocriptine—Dry mouth—Epirubicin—prostate cancer	6.03e-05	0.000254	CcSEcCtD
Bromocriptine—Vertigo—Doxorubicin—prostate cancer	6.02e-05	0.000254	CcSEcCtD
Bromocriptine—Syncope—Doxorubicin—prostate cancer	6.01e-05	0.000253	CcSEcCtD
Bromocriptine—Urticaria—Prednisone—prostate cancer	6.01e-05	0.000253	CcSEcCtD
Bromocriptine—Diarrhoea—Docetaxel—prostate cancer	6e-05	0.000253	CcSEcCtD
Bromocriptine—Abdominal pain—Prednisone—prostate cancer	5.98e-05	0.000252	CcSEcCtD
Bromocriptine—Body temperature increased—Prednisone—prostate cancer	5.98e-05	0.000252	CcSEcCtD
Bromocriptine—Confusional state—Epirubicin—prostate cancer	5.96e-05	0.000251	CcSEcCtD
Bromocriptine—Oedema—Epirubicin—prostate cancer	5.91e-05	0.000249	CcSEcCtD
Bromocriptine—Loss of consciousness—Doxorubicin—prostate cancer	5.89e-05	0.000248	CcSEcCtD
Bromocriptine—Infection—Epirubicin—prostate cancer	5.87e-05	0.000247	CcSEcCtD
Bromocriptine—Shock—Epirubicin—prostate cancer	5.82e-05	0.000245	CcSEcCtD
Bromocriptine—Convulsion—Doxorubicin—prostate cancer	5.81e-05	0.000245	CcSEcCtD
Bromocriptine—Diarrhoea—Capecitabine—prostate cancer	5.81e-05	0.000244	CcSEcCtD
Bromocriptine—Nervous system disorder—Epirubicin—prostate cancer	5.8e-05	0.000244	CcSEcCtD
Bromocriptine—Dizziness—Docetaxel—prostate cancer	5.8e-05	0.000244	CcSEcCtD
Bromocriptine—Hypertension—Doxorubicin—prostate cancer	5.79e-05	0.000244	CcSEcCtD
Bromocriptine—Tachycardia—Epirubicin—prostate cancer	5.77e-05	0.000243	CcSEcCtD
Bromocriptine—Skin disorder—Epirubicin—prostate cancer	5.74e-05	0.000242	CcSEcCtD
Bromocriptine—Anxiety—Doxorubicin—prostate cancer	5.69e-05	0.000239	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	5.67e-05	0.000239	CcSEcCtD
Bromocriptine—Anorexia—Epirubicin—prostate cancer	5.64e-05	0.000237	CcSEcCtD
Bromocriptine—Dizziness—Capecitabine—prostate cancer	5.61e-05	0.000236	CcSEcCtD
Bromocriptine—Dry mouth—Doxorubicin—prostate cancer	5.58e-05	0.000235	CcSEcCtD
Bromocriptine—Vomiting—Docetaxel—prostate cancer	5.57e-05	0.000235	CcSEcCtD
Bromocriptine—Rash—Docetaxel—prostate cancer	5.53e-05	0.000233	CcSEcCtD
Bromocriptine—Hypotension—Epirubicin—prostate cancer	5.52e-05	0.000233	CcSEcCtD
Bromocriptine—Dermatitis—Docetaxel—prostate cancer	5.52e-05	0.000233	CcSEcCtD
Bromocriptine—Confusional state—Doxorubicin—prostate cancer	5.52e-05	0.000232	CcSEcCtD
Bromocriptine—Headache—Docetaxel—prostate cancer	5.49e-05	0.000231	CcSEcCtD
Bromocriptine—Oedema—Doxorubicin—prostate cancer	5.47e-05	0.00023	CcSEcCtD
Bromocriptine—Infection—Doxorubicin—prostate cancer	5.43e-05	0.000229	CcSEcCtD
Bromocriptine—Asthenia—Prednisone—prostate cancer	5.42e-05	0.000228	CcSEcCtD
Bromocriptine—Vomiting—Capecitabine—prostate cancer	5.4e-05	0.000227	CcSEcCtD
Bromocriptine—Shock—Doxorubicin—prostate cancer	5.38e-05	0.000227	CcSEcCtD
Bromocriptine—Nervous system disorder—Doxorubicin—prostate cancer	5.36e-05	0.000226	CcSEcCtD
Bromocriptine—Rash—Capecitabine—prostate cancer	5.35e-05	0.000225	CcSEcCtD
Bromocriptine—Insomnia—Epirubicin—prostate cancer	5.35e-05	0.000225	CcSEcCtD
Bromocriptine—Dermatitis—Capecitabine—prostate cancer	5.35e-05	0.000225	CcSEcCtD
Bromocriptine—Tachycardia—Doxorubicin—prostate cancer	5.34e-05	0.000225	CcSEcCtD
Bromocriptine—Headache—Capecitabine—prostate cancer	5.32e-05	0.000224	CcSEcCtD
Bromocriptine—Skin disorder—Doxorubicin—prostate cancer	5.31e-05	0.000224	CcSEcCtD
Bromocriptine—Paraesthesia—Epirubicin—prostate cancer	5.31e-05	0.000224	CcSEcCtD
Bromocriptine—Dyspnoea—Epirubicin—prostate cancer	5.27e-05	0.000222	CcSEcCtD
Bromocriptine—Somnolence—Epirubicin—prostate cancer	5.26e-05	0.000221	CcSEcCtD
Bromocriptine—Anorexia—Doxorubicin—prostate cancer	5.21e-05	0.00022	CcSEcCtD
Bromocriptine—Nausea—Docetaxel—prostate cancer	5.21e-05	0.000219	CcSEcCtD
Bromocriptine—Dyspepsia—Epirubicin—prostate cancer	5.2e-05	0.000219	CcSEcCtD
Bromocriptine—Diarrhoea—Prednisone—prostate cancer	5.17e-05	0.000218	CcSEcCtD
Bromocriptine—Decreased appetite—Epirubicin—prostate cancer	5.14e-05	0.000216	CcSEcCtD
Bromocriptine—Hypotension—Doxorubicin—prostate cancer	5.11e-05	0.000215	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Epirubicin—prostate cancer	5.1e-05	0.000215	CcSEcCtD
Bromocriptine—Fatigue—Epirubicin—prostate cancer	5.1e-05	0.000215	CcSEcCtD
Bromocriptine—Constipation—Epirubicin—prostate cancer	5.06e-05	0.000213	CcSEcCtD
Bromocriptine—Nausea—Capecitabine—prostate cancer	5.04e-05	0.000212	CcSEcCtD
Bromocriptine—Dizziness—Prednisone—prostate cancer	5e-05	0.00021	CcSEcCtD
Bromocriptine—Insomnia—Doxorubicin—prostate cancer	4.95e-05	0.000208	CcSEcCtD
Bromocriptine—Paraesthesia—Doxorubicin—prostate cancer	4.91e-05	0.000207	CcSEcCtD
Bromocriptine—Dyspnoea—Doxorubicin—prostate cancer	4.88e-05	0.000205	CcSEcCtD
Bromocriptine—Feeling abnormal—Epirubicin—prostate cancer	4.87e-05	0.000205	CcSEcCtD
Bromocriptine—Somnolence—Doxorubicin—prostate cancer	4.86e-05	0.000205	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Epirubicin—prostate cancer	4.83e-05	0.000204	CcSEcCtD
Bromocriptine—Dyspepsia—Doxorubicin—prostate cancer	4.82e-05	0.000203	CcSEcCtD
Bromocriptine—Vomiting—Prednisone—prostate cancer	4.81e-05	0.000202	CcSEcCtD
Bromocriptine—Rash—Prednisone—prostate cancer	4.77e-05	0.000201	CcSEcCtD
Bromocriptine—Dermatitis—Prednisone—prostate cancer	4.76e-05	0.000201	CcSEcCtD
Bromocriptine—Decreased appetite—Doxorubicin—prostate cancer	4.76e-05	0.0002	CcSEcCtD
Bromocriptine—Headache—Prednisone—prostate cancer	4.74e-05	0.000199	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Doxorubicin—prostate cancer	4.72e-05	0.000199	CcSEcCtD
Bromocriptine—Fatigue—Doxorubicin—prostate cancer	4.72e-05	0.000199	CcSEcCtD
Bromocriptine—Urticaria—Epirubicin—prostate cancer	4.7e-05	0.000198	CcSEcCtD
Bromocriptine—Constipation—Doxorubicin—prostate cancer	4.68e-05	0.000197	CcSEcCtD
Bromocriptine—Body temperature increased—Epirubicin—prostate cancer	4.67e-05	0.000197	CcSEcCtD
Bromocriptine—Abdominal pain—Epirubicin—prostate cancer	4.67e-05	0.000197	CcSEcCtD
Bromocriptine—Feeling abnormal—Doxorubicin—prostate cancer	4.51e-05	0.00019	CcSEcCtD
Bromocriptine—Nausea—Prednisone—prostate cancer	4.49e-05	0.000189	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Doxorubicin—prostate cancer	4.47e-05	0.000188	CcSEcCtD
Bromocriptine—Urticaria—Doxorubicin—prostate cancer	4.35e-05	0.000183	CcSEcCtD
Bromocriptine—Abdominal pain—Doxorubicin—prostate cancer	4.32e-05	0.000182	CcSEcCtD
Bromocriptine—Body temperature increased—Doxorubicin—prostate cancer	4.32e-05	0.000182	CcSEcCtD
Bromocriptine—Asthenia—Epirubicin—prostate cancer	4.24e-05	0.000179	CcSEcCtD
Bromocriptine—Diarrhoea—Epirubicin—prostate cancer	4.05e-05	0.00017	CcSEcCtD
Bromocriptine—Asthenia—Doxorubicin—prostate cancer	3.93e-05	0.000165	CcSEcCtD
Bromocriptine—Dizziness—Epirubicin—prostate cancer	3.91e-05	0.000165	CcSEcCtD
Bromocriptine—Vomiting—Epirubicin—prostate cancer	3.76e-05	0.000158	CcSEcCtD
Bromocriptine—Diarrhoea—Doxorubicin—prostate cancer	3.74e-05	0.000158	CcSEcCtD
Bromocriptine—Rash—Epirubicin—prostate cancer	3.73e-05	0.000157	CcSEcCtD
Bromocriptine—Dermatitis—Epirubicin—prostate cancer	3.72e-05	0.000157	CcSEcCtD
Bromocriptine—Headache—Epirubicin—prostate cancer	3.7e-05	0.000156	CcSEcCtD
Bromocriptine—Dizziness—Doxorubicin—prostate cancer	3.62e-05	0.000152	CcSEcCtD
Bromocriptine—Nausea—Epirubicin—prostate cancer	3.51e-05	0.000148	CcSEcCtD
Bromocriptine—Vomiting—Doxorubicin—prostate cancer	3.48e-05	0.000146	CcSEcCtD
Bromocriptine—Rash—Doxorubicin—prostate cancer	3.45e-05	0.000145	CcSEcCtD
Bromocriptine—Dermatitis—Doxorubicin—prostate cancer	3.45e-05	0.000145	CcSEcCtD
Bromocriptine—Headache—Doxorubicin—prostate cancer	3.43e-05	0.000144	CcSEcCtD
Bromocriptine—Nausea—Doxorubicin—prostate cancer	3.25e-05	0.000137	CcSEcCtD
Bromocriptine—ADRA2B—Signaling Pathways—VEGFA—prostate cancer	2.17e-06	1.42e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—STAT3—prostate cancer	2.17e-06	1.42e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—MDM2—prostate cancer	2.17e-06	1.42e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CASP3—prostate cancer	2.17e-06	1.42e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—IL2—prostate cancer	2.17e-06	1.42e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—MTHFR—prostate cancer	2.17e-06	1.42e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—EGFR—prostate cancer	2.17e-06	1.42e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—EGFR—prostate cancer	2.17e-06	1.42e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—INS—prostate cancer	2.16e-06	1.41e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—AKT1—prostate cancer	2.16e-06	1.41e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—IL6—prostate cancer	2.16e-06	1.41e-05	CbGpPWpGaD
Bromocriptine—HTR2A—GPCR downstream signaling—AKT1—prostate cancer	2.16e-06	1.41e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—SRC—prostate cancer	2.16e-06	1.41e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—STAT3—prostate cancer	2.15e-06	1.41e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—PIK3CA—prostate cancer	2.15e-06	1.41e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—RXRA—prostate cancer	2.15e-06	1.4e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—EP300—prostate cancer	2.15e-06	1.4e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—SRC—prostate cancer	2.14e-06	1.4e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—TP53—prostate cancer	2.14e-06	1.4e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—ERBB2—prostate cancer	2.14e-06	1.4e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—TP53—prostate cancer	2.14e-06	1.4e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CASP3—prostate cancer	2.14e-06	1.4e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CDKN1B—prostate cancer	2.14e-06	1.39e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—IL2—prostate cancer	2.13e-06	1.39e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PPARA—prostate cancer	2.13e-06	1.39e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—TP53—prostate cancer	2.13e-06	1.39e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—IL6—prostate cancer	2.12e-06	1.39e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—PIK3CA—prostate cancer	2.12e-06	1.38e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—CREBBP—prostate cancer	2.12e-06	1.38e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CCND1—prostate cancer	2.11e-06	1.38e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—PIK3CB—prostate cancer	2.11e-06	1.38e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR downstream signaling—AKT1—prostate cancer	2.11e-06	1.38e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—EP300—prostate cancer	2.11e-06	1.38e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—VEGFA—prostate cancer	2.1e-06	1.37e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CTNNB1—prostate cancer	2.09e-06	1.37e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CASP3—prostate cancer	2.09e-06	1.37e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—IL2—prostate cancer	2.09e-06	1.36e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—VEGFA—prostate cancer	2.09e-06	1.36e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—SRC—prostate cancer	2.09e-06	1.36e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—EP300—prostate cancer	2.08e-06	1.36e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—TP53—prostate cancer	2.08e-06	1.36e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CCND1—prostate cancer	2.08e-06	1.36e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—IL6—prostate cancer	2.08e-06	1.36e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—STAT3—prostate cancer	2.08e-06	1.36e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—KRAS—prostate cancer	2.08e-06	1.36e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—COMT—prostate cancer	2.07e-06	1.35e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—STAT3—prostate cancer	2.07e-06	1.35e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CTNNB1—prostate cancer	2.06e-06	1.35e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—GSTP1—prostate cancer	2.06e-06	1.35e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—SRC—prostate cancer	2.05e-06	1.34e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—MMP9—prostate cancer	2.05e-06	1.34e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—TP53—prostate cancer	2.05e-06	1.34e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—KRAS—prostate cancer	2.05e-06	1.34e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—KRAS—prostate cancer	2.05e-06	1.34e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CDKN1A—prostate cancer	2.05e-06	1.34e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—PTEN—prostate cancer	2.04e-06	1.33e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CCND1—prostate cancer	2.04e-06	1.33e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CXCL8—prostate cancer	2.03e-06	1.33e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—VEGFA—prostate cancer	2.03e-06	1.33e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—ITPR1—prostate cancer	2.03e-06	1.32e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—PIK3CA—prostate cancer	2.02e-06	1.32e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—MMP9—prostate cancer	2.02e-06	1.32e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—MYC—prostate cancer	2.02e-06	1.32e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CTNNB1—prostate cancer	2.02e-06	1.32e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—TGFB1—prostate cancer	2.01e-06	1.32e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CDKN1A—prostate cancer	2.01e-06	1.31e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—STAT3—prostate cancer	2.01e-06	1.31e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—PTEN—prostate cancer	2.01e-06	1.31e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PIK3CD—prostate cancer	2.01e-06	1.31e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—MYC—prostate cancer	2e-06	1.31e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—CAV1—prostate cancer	2e-06	1.31e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—VEGFA—prostate cancer	2e-06	1.31e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—TGFB1—prostate cancer	2e-06	1.3e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—AKT1—prostate cancer	1.99e-06	1.3e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CDKN1B—prostate cancer	1.98e-06	1.3e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—STAT3—prostate cancer	1.98e-06	1.29e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—MMP9—prostate cancer	1.98e-06	1.29e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—EGFR—prostate cancer	1.98e-06	1.29e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CDKN1A—prostate cancer	1.97e-06	1.29e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—PTEN—prostate cancer	1.97e-06	1.28e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR downstream signaling—AKT1—prostate cancer	1.96e-06	1.28e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—IL6—prostate cancer	1.96e-06	1.28e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—IL6—prostate cancer	1.96e-06	1.28e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—AKT1—prostate cancer	1.96e-06	1.28e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—EGFR—prostate cancer	1.96e-06	1.28e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—TP53—prostate cancer	1.96e-06	1.28e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—IL6—prostate cancer	1.95e-06	1.27e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—EP300—prostate cancer	1.95e-06	1.27e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CASP3—prostate cancer	1.94e-06	1.27e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—IL2—prostate cancer	1.94e-06	1.27e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—IL6—prostate cancer	1.93e-06	1.26e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—MYC—prostate cancer	1.93e-06	1.26e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—TGFB1—prostate cancer	1.93e-06	1.26e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—MYC—prostate cancer	1.92e-06	1.26e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—AKT1—prostate cancer	1.92e-06	1.25e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—TGFB1—prostate cancer	1.92e-06	1.25e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—TYMS—prostate cancer	1.92e-06	1.25e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—EP300—prostate cancer	1.92e-06	1.25e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.91e-06	1.25e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—PIK3CA—prostate cancer	1.91e-06	1.25e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—IL6—prostate cancer	1.91e-06	1.24e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—PIK3CA—prostate cancer	1.9e-06	1.24e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—NOS3—prostate cancer	1.89e-06	1.24e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—GSTM1—prostate cancer	1.89e-06	1.24e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CCND1—prostate cancer	1.89e-06	1.24e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—SRC—prostate cancer	1.89e-06	1.24e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—EGFR—prostate cancer	1.89e-06	1.23e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—PIK3CA—prostate cancer	1.88e-06	1.23e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—PIK3CA—prostate cancer	1.88e-06	1.23e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—EGFR—prostate cancer	1.88e-06	1.23e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—IL6—prostate cancer	1.88e-06	1.23e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—EP300—prostate cancer	1.88e-06	1.22e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CTNNB1—prostate cancer	1.87e-06	1.22e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—MYC—prostate cancer	1.87e-06	1.22e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—KRAS—prostate cancer	1.87e-06	1.22e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—TGFB1—prostate cancer	1.86e-06	1.22e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—SRC—prostate cancer	1.86e-06	1.22e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—LPL—prostate cancer	1.86e-06	1.21e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—KRAS—prostate cancer	1.85e-06	1.21e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—TP53—prostate cancer	1.84e-06	1.2e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—VEGFA—prostate cancer	1.84e-06	1.2e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—MYC—prostate cancer	1.84e-06	1.2e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—MMP9—prostate cancer	1.84e-06	1.2e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—TGFB1—prostate cancer	1.84e-06	1.2e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CDKN1A—prostate cancer	1.83e-06	1.2e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—EGFR—prostate cancer	1.83e-06	1.19e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—PTEN—prostate cancer	1.83e-06	1.19e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—STAT3—prostate cancer	1.83e-06	1.19e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—SRC—prostate cancer	1.82e-06	1.19e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PIK3CG—prostate cancer	1.82e-06	1.19e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—TP53—prostate cancer	1.82e-06	1.19e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—TP53—prostate cancer	1.82e-06	1.19e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—VEGFA—prostate cancer	1.81e-06	1.18e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—AKT1—prostate cancer	1.81e-06	1.18e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—AKT1—prostate cancer	1.81e-06	1.18e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—EGFR—prostate cancer	1.8e-06	1.18e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—AKT1—prostate cancer	1.8e-06	1.17e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—STAT3—prostate cancer	1.8e-06	1.17e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.79e-06	1.17e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—IL6—prostate cancer	1.79e-06	1.17e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—KRAS—prostate cancer	1.78e-06	1.17e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—AKT1—prostate cancer	1.78e-06	1.16e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—ERCC2—prostate cancer	1.78e-06	1.16e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—VEGFA—prostate cancer	1.78e-06	1.16e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—KRAS—prostate cancer	1.78e-06	1.16e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—AKT1—prostate cancer	1.76e-06	1.15e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—STAT3—prostate cancer	1.76e-06	1.15e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PIK3CB—prostate cancer	1.75e-06	1.14e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—EP300—prostate cancer	1.74e-06	1.14e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PTGS2—prostate cancer	1.73e-06	1.13e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—AKT1—prostate cancer	1.73e-06	1.13e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—KRAS—prostate cancer	1.73e-06	1.13e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—INS—prostate cancer	1.72e-06	1.13e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—PIK3CA—prostate cancer	1.71e-06	1.12e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—KRAS—prostate cancer	1.7e-06	1.11e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—PIK3CA—prostate cancer	1.7e-06	1.11e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—MYC—prostate cancer	1.7e-06	1.11e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—SRC—prostate cancer	1.69e-06	1.11e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—TGFB1—prostate cancer	1.69e-06	1.1e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—CREBBP—prostate cancer	1.69e-06	1.1e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—IL6—prostate cancer	1.69e-06	1.1e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—MTHFR—prostate cancer	1.67e-06	1.09e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—MYC—prostate cancer	1.67e-06	1.09e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—IL6—prostate cancer	1.67e-06	1.09e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—IL6—prostate cancer	1.67e-06	1.09e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—TGFB1—prostate cancer	1.66e-06	1.09e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—EGFR—prostate cancer	1.66e-06	1.08e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—TP53—prostate cancer	1.66e-06	1.08e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—AKT1—prostate cancer	1.65e-06	1.08e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—VEGFA—prostate cancer	1.65e-06	1.08e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—TP53—prostate cancer	1.64e-06	1.07e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PPARA—prostate cancer	1.64e-06	1.07e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—PIK3CA—prostate cancer	1.64e-06	1.07e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—MYC—prostate cancer	1.63e-06	1.07e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—STAT3—prostate cancer	1.63e-06	1.07e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—EGFR—prostate cancer	1.63e-06	1.07e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—PIK3CA—prostate cancer	1.63e-06	1.07e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—TGFB1—prostate cancer	1.63e-06	1.06e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PIK3CD—prostate cancer	1.6e-06	1.05e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—EGFR—prostate cancer	1.6e-06	1.04e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—PIK3CA—prostate cancer	1.59e-06	1.04e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—TP53—prostate cancer	1.59e-06	1.04e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—TP53—prostate cancer	1.58e-06	1.03e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—KRAS—prostate cancer	1.57e-06	1.02e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—PIK3CA—prostate cancer	1.56e-06	1.02e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—AKT1—prostate cancer	1.56e-06	1.02e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—AKT1—prostate cancer	1.55e-06	1.01e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—CAV1—prostate cancer	1.54e-06	1.01e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—KRAS—prostate cancer	1.54e-06	1.01e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—PIK3CA—prostate cancer	1.54e-06	1.01e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—AKT1—prostate cancer	1.54e-06	1e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—AKT1—prostate cancer	1.54e-06	1e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—TP53—prostate cancer	1.54e-06	1e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—MYC—prostate cancer	1.52e-06	9.92e-06	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—IL6—prostate cancer	1.52e-06	9.91e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—TGFB1—prostate cancer	1.51e-06	9.89e-06	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—NOS3—prostate cancer	1.51e-06	9.88e-06	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PTEN—prostate cancer	1.51e-06	9.87e-06	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—TP53—prostate cancer	1.51e-06	9.87e-06	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—KRAS—prostate cancer	1.51e-06	9.86e-06	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—IL6—prostate cancer	1.5e-06	9.82e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—EGFR—prostate cancer	1.49e-06	9.7e-06	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—IL6—prostate cancer	1.45e-06	9.48e-06	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—IL6—prostate cancer	1.44e-06	9.43e-06	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—EP300—prostate cancer	1.44e-06	9.41e-06	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—PIK3CA—prostate cancer	1.44e-06	9.4e-06	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—PIK3CA—prostate cancer	1.42e-06	9.25e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.41e-06	9.18e-06	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—IL6—prostate cancer	1.41e-06	9.18e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—KRAS—prostate cancer	1.4e-06	9.16e-06	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—AKT1—prostate cancer	1.4e-06	9.15e-06	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PIK3CB—prostate cancer	1.4e-06	9.12e-06	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—TP53—prostate cancer	1.39e-06	9.1e-06	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—AKT1—prostate cancer	1.39e-06	9.06e-06	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—PIK3CA—prostate cancer	1.39e-06	9.06e-06	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PTGS2—prostate cancer	1.38e-06	9.03e-06	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—IL6—prostate cancer	1.38e-06	9.03e-06	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—TP53—prostate cancer	1.37e-06	8.95e-06	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—TP53—prostate cancer	1.34e-06	8.76e-06	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—AKT1—prostate cancer	1.34e-06	8.75e-06	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—AKT1—prostate cancer	1.33e-06	8.7e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—INS—prostate cancer	1.33e-06	8.69e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—CREBBP—prostate cancer	1.3e-06	8.51e-06	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—AKT1—prostate cancer	1.3e-06	8.47e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—PIK3CA—prostate cancer	1.29e-06	8.42e-06	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—AKT1—prostate cancer	1.28e-06	8.33e-06	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—IL6—prostate cancer	1.27e-06	8.33e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—AKT1—prostate cancer	1.26e-06	8.22e-06	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—IL6—prostate cancer	1.25e-06	8.19e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—TP53—prostate cancer	1.25e-06	8.14e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.24e-06	8.07e-06	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—IL6—prostate cancer	1.23e-06	8.02e-06	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PTEN—prostate cancer	1.21e-06	7.88e-06	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—AKT1—prostate cancer	1.18e-06	7.68e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—NOS3—prostate cancer	1.17e-06	7.62e-06	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—AKT1—prostate cancer	1.16e-06	7.56e-06	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—EP300—prostate cancer	1.15e-06	7.51e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—IL6—prostate cancer	1.14e-06	7.45e-06	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—AKT1—prostate cancer	1.13e-06	7.4e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.08e-06	7.04e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PTGS2—prostate cancer	1.07e-06	6.97e-06	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PIK3CA—prostate cancer	1.07e-06	6.96e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—AKT1—prostate cancer	1.05e-06	6.88e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PTEN—prostate cancer	9.31e-07	6.08e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—EP300—prostate cancer	8.88e-07	5.8e-06	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—AKT1—prostate cancer	8.71e-07	5.69e-06	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PIK3CA—prostate cancer	8.51e-07	5.56e-06	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—AKT1—prostate cancer	6.95e-07	4.54e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PIK3CA—prostate cancer	6.57e-07	4.29e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—AKT1—prostate cancer	5.36e-07	3.5e-06	CbGpPWpGaD
